Trust Company of Vermont’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.83M Sell
39,867
-3,654
-8% -$355K 0.16% 107
2025
Q3
$4.14M Sell
43,521
-4,391
-9% -$404K 0.18% 104
2025
Q2
$4.18M Sell
47,912
-2,316
-5% -$196K 0.2% 105
2025
Q1
$4.51M Sell
50,228
-1,701
-3% -$152K 0.23% 99
2024
Q4
$4.15M Sell
51,929
-12,020
-19% -$1.04M 0.2% 101
2024
Q3
$5.76M Sell
63,949
-2,333
-4% -$196K 0.29% 84
2024
Q2
$5.22M Sell
66,282
-1,411
-2% -$116K 0.28% 86
2024
Q1
$5.9M Sell
67,693
-62
-0.1% -$5.29K 0.33% 76
2023
Q4
$5.58M Sell
67,755
-5,303
-7% -$404K 0.37% 69
2023
Q3
$5.72M Sell
73,058
-696
-0.9% -$58.3K 0.39% 71
2023
Q2
$6.5M Buy
73,754
+4,587
+7% +$395K 0.42% 67
2023
Q1
$5.58M Buy
69,167
+3,202
+5% +$261K 0.39% 74
2022
Q4
$5.13M Buy
65,965
+7,878
+14% +$639K 0.38% 77
2022
Q3
$4.69M Buy
58,087
+22,133
+62% +$1.99M 0.37% 83
2022
Q2
$3.23M Buy
35,954
+11,051
+44% +$1.12M 0.25% 106
2022
Q1
$2.76M Buy
24,903
+775
+3% +$81.9K 0.19% 113
2021
Q4
$2.5M Buy
24,128
+730
+3% +$84.5K 0.16% 126
2021
Q3
$2.93M Sell
23,398
-179
-0.8% -$23.2K 0.21% 113
2021
Q2
$2.93M Buy
23,577
+1,502
+7% +$189K 0.2% 113
2021
Q1
$2.61M Buy
22,075
+1,527
+7% +$179K 0.2% 117
2020
Q4
$2.41M Buy
20,548
+1,202
+6% +$132K 0.19% 114
2020
Q3
$2.01M Buy
19,346
+73
+0.4% +$7.33K 0.18% 111
2020
Q2
$1.77M Sell
19,273
-3,260
-14% -$313K 0.17% 113
2020
Q1
$2.03M Buy
22,533
+508
+2% +$54K 0.19% 106
2019
Q4
$2.5M Buy
22,025
+1,491
+7% +$164K 0.19% 109
2019
Q3
$2.23M Buy
20,534
+865
+4% +$90.3K 0.18% 115
2019
Q2
$1.92M Buy
19,669
+1,365
+7% +$125K 0.16% 123
2019
Q1
$1.67M Buy
18,304
+2,199
+14% +$197K 0.14% 132
2018
Q4
$1.47M Sell
16,105
-70
-0.4% -$6.54K 0.14% 132
2018
Q3
$1.59M Buy
16,175
+1,063
+7% +$98.3K 0.13% 140
2018
Q2
$1.29M Buy
15,112
+1,311
+9% +$110K 0.12% 150
2018
Q1
$1.11M Sell
13,801
-1,274
-8% -$105K 0.1% 160
2017
Q4
$1.22M Sell
15,075
-961
-6% -$77K 0.11% 161
2017
Q3
$1.25M Sell
16,036
-589
-4% -$48.9K 0.12% 152
2017
Q2
$1.48M Buy
16,625
+712
+4% +$60K 0.15% 134
2017
Q1
$1.28M Sell
15,913
-1,714
-10% -$134K 0.14% 139
2016
Q4
$1.26M Buy
17,627
+455
+3% +$35.7K 0.14% 136
2016
Q3
$1.48M Sell
17,172
-113
-0.7% -$9.85K 0.19% 122
2016
Q2
$1.5M Sell
17,285
-205
-1% -$16.6K 0.2% 118
2016
Q1
$1.31M Sell
17,490
-2,268
-11% -$171K 0.18% 125
2015
Q4
$1.52M Sell
19,758
-11,183
-36% -$842K 0.22% 115
2015
Q3
$2.07M Sell
30,941
-38,152
-55% -$2.81M 0.32% 95
2015
Q2
$5.12M Sell
69,093
-14,922
-18% -$1.14M 0.74% 39
2015
Q1
$6.55M Buy
84,015
+59,081
+237% +$4.48M 0.95% 34
2014
Q4
$1.8M Sell
24,934
-873
-3% -$60.6K 0.26% 106
2014
Q3
$1.6M Sell
25,807
-426
-2% -$27.1K 0.24% 114
2014
Q2
$1.67M Sell
26,233
-616
-2% -$37.4K 0.26% 106
2014
Q1
$1.65M Sell
26,849
-1,048
-4% -$61K 0.27% 102
2013
Q4
$1.6M Buy
27,897
+196
+0.7% +$11.1K 0.27% 100
2013
Q3
$1.48M Sell
27,701
-93
-0.3% -$5K 0.27% 102
2013
Q2
$1.43M Buy
+27,794
New +$1.37M 0.28% 99

Other funds holding MDT

Trust Company of Vermont's MDT Position: Q4 2025 in Review

Trust Company of Vermont reduced its Medtronic (MDT) stake by 8.4% in Q4 2025, selling an estimated $355K and leaving 39,867 shares worth $3.83M. The position accounts for 0.16% of the portfolio, ranked #107.

Trust Company of Vermont first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.55M in Q1 2015. 2,305 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Trust Company of Vermont held 39,867 shares of Medtronic worth $3.83M as of Q4 2025.
  • Trust Company of Vermont sold 3,654 Medtronic shares in Q4 2025, an estimated $355K.
  • Medtronic made up 0.16% of Trust Company of Vermont's portfolio in Q4 2025, its #107 holding.
  • Trust Company of Vermont first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • Trust Company of Vermont's Medtronic position peaked at $6.55M in Q1 2015.
  • 2,305 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.